The Effect of Remifentanil-dexmedetomidine Compared With Remifentanil-midazolam on Patient's Satisfaction

• Status: Completed
• Trial end date: 2018-04-02
• Target enrollment: 0
• Participant gender: Male

Summary

Percutaneous trans-arterial angioplasty(PTA) is one of the peripheral arterial occlusive disease(PAOD) treatment. During and after PTA, ischemia-reperfusion pain is induced so proper analgesia is important. ischemia-reperfusion injury is due to reactive oxygen species. Dexmedetomidine has analgesic, sedative and anti oxidant effect. So the investigators research the patient's satisfaction that are given the dexmedetomidine during PTA procedure.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Yonsei University
• Treatments: Dexmedetomidine; Midazolam; Remifentanil

Criteria

Inclusion Criteria:

• patients who are scheduled to undergo percutaneous trans-arterial angioplasty

• American Society of Anesthesiologists (ASA) class I, II, III

Exclusion Criteria: Subjects are ineligible if they have the below condition

• psychiatric medication

• myocardial infarction within 1 year

• cardiac surgery within 1 year

• heart failure

• fever (>38 degree)

• uncontrolled hypertension

• cognitive dysfunction

• disabling mental change disorder

• being unable to communicate or speak Korean